DANIEL BRADBURY
CIK 1236397 · CHAIRMAN · last filed 2026-07-28
DANIEL BRADBURY is a CHAIRMAN who has filed 276 SEC Form 4 insider transactions across 11 companies since 2007. The most recent filing, for VANI, was dated Jul 28, 2026. Across all open-market trades the lifetime net is −$176.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $25.5M across reported positions. 86 SEC filings were submitted jointly with ILLUMINA, INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$25.51M
11
276
-$176.51M
Filer Profile
2223 AVENIDA DE LA PLAYA, SUITE 108
LA JOLLA, CA 92037
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VANI | Director | — | $1.27 | — | $0 | 8 | 2026-07-28 |
| CSTL | Director | 35,631 | $32.33 | $1.15M | -$160.98M | 91 | 2026-06-01 |
| EQ | CHAIRMAN | 2,969,596 | $2.11 | $6.27M | $0 | 11 | 2026-05-29 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 39,471 | $19.00 | $749.9K | $500.0K | 9 | 2023-05-25 |
| Nuvation Bio Inc. (NUVB.WS) Delisted | Director | 25,000 | $0.01 | $128 | $0 | 1 | 2021-02-26 |
| GERN | Director | 51,323 | $1.35 | $69.3K | $0 | 12 | 2019-04-01 |
| CORT | Director | 130,575 | $112.79 | $14.73M | -$480.2K | 16 | 2019-02-12 |
| ILMN | Director | 15,924 | $206.45 | $3.29M | -$14.97M | 79 | 2017-05-26 |
| BMR | Director | 4,139 | $1.35 | $5.6K | $0 | 1 | 2013-01-03 |
| AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | President & Chief Executive Of | 127,235 | — | — | -$574.8K | 30 | 2012-07-26 |
| Paratek Pharmaceuticals, Inc. (NOVC) Delisted | Director | 35,714 | — | — | $0 | 3 | 2008-02-15 |
Recent Filings
276 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-28 | VANI | Grant (A) | — | $0 | EDGAR |
| 2026-06-25 | VANI | Grant (A) | — | $0 | EDGAR |
| 2026-06-01 | CSTL | Grant (A) | — | $0 | EDGAR |
| 2026-05-29 | EQ | Grant (A) | — | $0 | EDGAR |
| 2026-05-27 | CSTL | Exer (M) | +13,667 | $0 | EDGAR |
| 2026-01-05 | VANI | Grant (A) | — | $0 | EDGAR |
| 2025-06-26 | VANI | Mixed | — | $0 | EDGAR |
| 2025-05-23 | CSTL | Mixed | +8,673 | $0 | EDGAR |
| 2025-02-19 | EQ | Mixed | — | $0 | EDGAR |
| 2025-02-07 | CSTL | Sell (S) | −7,867 | -$221.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.